Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,334 across all filing types
Latest filing 2020-10-13 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
COVID-19 ANTIBODIES ADVANCE AND GET US FUNDING
Foreign Filer Report
2020-10-13 English
COVID-19 antibodies advance and get US funding
Regulatory Filings Classification · 99% confidence The document is clearly identified as originating from 'RNS Number : 7043B' and contains a date stamp typical of regulatory news services. The content describes a significant corporate development—advancing a COVID-19 antibody combination (AZD7442) into Phase III trials and securing US government funding. This type of announcement, which is a material update released via a recognized news service (RNS, approved by the FCA), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). While it is an announcement, it is not specifically announcing the publication of a pre-existing report (which would be RPA). Therefore, RNS is the most appropriate classification for this general regulatory news release.
2020-10-12 English
FARXIGA GRANTED US BTD IN CHRONIC KIDNEY DISEASE
Foreign Filer Report
2020-10-02 English
Farxiga granted US BTD in chronic kidney disease
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 9311A' and contains information released on '02 October 2020' via 'RNS, the news service of the London Stock Exchange'. The content is a press release announcing a regulatory/clinical development ('Farxiga granted Breakthrough Therapy Designation in US for chronic kidney disease'). Since this is a general regulatory announcement disseminated through the RNS system that does not fit into specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings category, RNS.
2020-10-02 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2020-10-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a notification filed via RNS (London Stock Exchange's news service) under the Transparency Directive. It explicitly states the total number of voting rights and the issued share capital as of a specific date (30 September 2020). This type of filing relates to changes in capital structure or voting rights denominator, which is often associated with regulatory disclosures concerning share ownership thresholds. However, none of the specific codes (like DVA for voting results or SHA for share issue) perfectly capture a routine 'Voting rights and capital' notification under the Disclosure and Transparency Rules, unless it is a general regulatory announcement. Since it is explicitly distributed via RNS and deals with regulatory disclosure rules (DTR 5.6.1), and it is not a full report, the most appropriate general regulatory category is RNS, as it is a standard regulatory update distributed through the primary information provider.
2020-10-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.